Turnstone Biologics (TSBX) Competitors $0.36 +0.00 (+0.53%) As of 07/3/2025 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TSBX vs. ABVC, PLUR, LVTX, ESLA, LTRN, OKUR, XLO, BDRX, MDCX, and RNTXShould you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include ABVC BioPharma (ABVC), Pluri (PLUR), LAVA Therapeutics (LVTX), Estrella Immunopharma (ESLA), Lantern Pharma (LTRN), OnKure Therapeutics (OKUR), Xilio Therapeutics (XLO), Biodexa Pharmaceuticals (BDRX), Medicus Pharma (MDCX), and Rein Therapeutics (RNTX). These companies are all part of the "pharmaceutical products" industry. Turnstone Biologics vs. Its Competitors ABVC BioPharma Pluri LAVA Therapeutics Estrella Immunopharma Lantern Pharma OnKure Therapeutics Xilio Therapeutics Biodexa Pharmaceuticals Medicus Pharma Rein Therapeutics ABVC BioPharma (NASDAQ:ABVC) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Which has better earnings and valuation, ABVC or TSBX? ABVC BioPharma has higher revenue and earnings than Turnstone Biologics. ABVC BioPharma is trading at a lower price-to-earnings ratio than Turnstone Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$510K100.88-$4.90M-$0.13-23.31Turnstone BiologicsN/AN/A-$70.84M-$2.73-0.13 Which has more volatility and risk, ABVC or TSBX? ABVC BioPharma has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Do insiders & institutionals have more ownership in ABVC or TSBX? 11.4% of ABVC BioPharma shares are owned by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are owned by institutional investors. 17.1% of ABVC BioPharma shares are owned by insiders. Comparatively, 32.1% of Turnstone Biologics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend ABVC or TSBX? Turnstone Biologics has a consensus target price of $0.45, suggesting a potential upside of 24.31%. Given Turnstone Biologics' stronger consensus rating and higher probable upside, analysts clearly believe Turnstone Biologics is more favorable than ABVC BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ABVC BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Turnstone Biologics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Does the media refer more to ABVC or TSBX? In the previous week, Turnstone Biologics had 2 more articles in the media than ABVC BioPharma. MarketBeat recorded 4 mentions for Turnstone Biologics and 2 mentions for ABVC BioPharma. Turnstone Biologics' average media sentiment score of 0.25 beat ABVC BioPharma's score of 0.00 indicating that Turnstone Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ABVC BioPharma 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Turnstone Biologics 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is ABVC or TSBX more profitable? Turnstone Biologics has a net margin of 0.00% compared to ABVC BioPharma's net margin of -963.46%. ABVC BioPharma's return on equity of -29.62% beat Turnstone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-963.46% -29.62% -14.08% Turnstone Biologics N/A -162.79%-124.10% SummaryTurnstone Biologics beats ABVC BioPharma on 9 of the 14 factors compared between the two stocks. Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TSBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSBX vs. The Competition Export to ExcelMetricTurnstone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.38M$2.89B$5.49B$9.01BDividend YieldN/A2.43%5.38%4.09%P/E Ratio-0.1321.5627.4220.26Price / SalesN/A245.52407.97121.21Price / CashN/A41.9536.6357.47Price / Book0.277.518.085.67Net Income-$70.84M-$55.05M$3.16B$248.47M7 Day Performance2.64%4.59%2.81%3.29%1 Month Performance4.47%4.86%3.68%5.19%1 Year Performance-83.91%5.82%35.29%21.35% Turnstone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSBXTurnstone Biologics1.6854 of 5 stars$0.36+0.5%$0.45+24.3%-83.9%$8.38MN/A-0.1382ABVCABVC BioPharma0.1687 of 5 stars$2.06+5.1%N/A+315.1%$34.98M$510K-15.8530News CoveragePLURPluri3.6137 of 5 stars$4.46+1.6%$12.00+169.1%+2.1%$34.92M$330K-0.81150News CoverageInsider TradeGap DownLVTXLAVA Therapeutics1.8584 of 5 stars$1.33+0.1%$3.17+138.8%-25.8%$34.89M$11.98M-1.2860ESLAEstrella Immunopharma2.254 of 5 stars$0.96+4.3%$16.00+1,566.7%-19.7%$34.72MN/A-3.69N/AGap UpLTRNLantern Pharma1.5727 of 5 stars$3.21+4.6%$25.00+678.8%-25.9%$34.62MN/A-1.7420News CoverageGap DownOKUROnKure Therapeutics2.7041 of 5 stars$2.56+6.2%$32.33+1,163.0%N/A$34.59MN/A-0.49N/AXLOXilio Therapeutics2.2182 of 5 stars$0.66-1.4%$4.00+505.7%-19.7%$34.20M$6.34M-0.7970News CoveragePositive NewsBDRXBiodexa Pharmaceuticals0.602 of 5 stars$0.92+0.1%N/AN/A$33.66M$470K0.0020Upcoming EarningsMDCXMedicus Pharma1.8749 of 5 stars$2.45+4.7%$23.50+859.2%N/A$33.25MN/A-2.11N/AAnalyst ForecastGap UpRNTXRein TherapeuticsN/A$1.47-2.0%N/AN/A$32.57MN/A-0.519Gap Up Related Companies and Tools Related Companies ABVC BioPharma Competitors Pluri Competitors LAVA Therapeutics Competitors Estrella Immunopharma Competitors Lantern Pharma Competitors OnKure Therapeutics Competitors Xilio Therapeutics Competitors Biodexa Pharmaceuticals Competitors Medicus Pharma Competitors Rein Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TSBX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSBX Stock Alerts